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Abstract. 
 
We report that a peripheral Golgi protein 
with a molecular mass of 210 kD localized at the cis-
Golgi network (Rios, R.M., A.M. Tassin, C. Celati, C. 
Antony, M.C. Boissier, J.C. Homberg, and M. Bornens. 
 
1994. 
 
J. Cell Biol.
 
 125:997—1013) is a microtubule-bind-
ing protein that associates in situ with a subpopulation 
of stable microtubules. Interaction of this protein, now 
called GMAP-210, for Golgi microtubule-associated 
protein 210, with microtubules in vitro is direct, tight 
and nucleotide-independent. Biochemical analysis fur-
ther suggests that GMAP-210 specifically binds to
microtubule ends. The full-length cDNA encoding 
GMAP-210 predicts a protein of 1,979 amino acids with 
a very long central coiled-coil domain. Deletion analy-
ses in vitro show that the COOH terminus of GMAP-
 
210 binds to microtubules whereas the NH
 
2
 
 terminus 
binds to Golgi membranes. Overexpression of GMAP-
210—encoding cDNA induced a dramatic enlargement 
of the Golgi apparatus and perturbations in the micro-
tubule network. These effects did not occur when a mu-
tant lacking the COOH-terminal domain was ex-
pressed. When transfected in fusion with the green 
fluorescent protein, the NH
 
2
 
-terminal domain associ-
ated with the cis-Golgi network whereas the COOH-
terminal microtubule-binding domain localized at the 
centrosome. Altogether these data support the view 
that GMAP-210 serves to link the cis-Golgi network to 
the minus ends of centrosome-nucleated microtubules. 
In addition, this interaction appears essential for ensur-
ing the proper morphology and size of the Golgi appa-
ratus.
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I
 
NTERPHASE
 
 microtubules are believed to play impor-
tant roles in establishment of cell polarity and organiza-
tion and distribution of organelles in higher eukaryotic
cells. It has become clear that all classes of membrane-
bound, cytoplasmic organelles maintain an intimate and
dynamic association with the microtubule cytoskeleton
(Cole and Lippincott-Schwartz, 1995). The endoplasmic
reticulum extends tubular membrane structures towards
cell periphery by using microtubule network as a scaffold
(Dabora and Sheetz, 1988). The Golgi complex colocalizes
with the minus ends of microtubules which are associated
with the centrosome (Kreis, 1990). Late endosomes and
lysosomes, generally located in the perinuclear area, also
display tubular shapes (Matteoni and Kreis, 1987). Re-
cently, involvement of microtubules in the spatial organi-
zation of peroxisomes and in the fast directional move-
ment of a small subpopulation of these organelles has
been reported (Wiemer et al., 1997). In each case, the
morphology and distribution of the organelles are dis-
rupted by microtubule-depolymerizing drugs.
Microtubules also support the movement of the mem-
branous organelles and their transport intermediates.
These intracellular movements that occur in opposite di-
rections along microtubules are thought to be driven by
two microtubule motors, kinesin (Vale et al., 1985a) which
moves towards the plus ends of microtubules (Vale et al.,
1985b), and cytoplasmic dynein which moves towards the
minus ends (Paschal and Vallee, 1987). Tubular lysosome
extension and anterograde lysosome membrane transport
require kinesin activity (Hollenbeck and Swanson, 1990;
Nakata and Hirokawa, 1995), and there exist evidences
consistent with a role for kinesin in the plus end–directed
extension of ER tubules to the cell periphery (Feiguin et
al., 1994). Retrograde transport from the Golgi apparatus
to the ER is a microtubule-dependent plus end–directed
movement also. Consistent with this, kinesin has been
shown to be present on membranes that constitutively cy-
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cle between the ER and the Golgi and microinjection of
an anti-kinesin antibody inhibited Golgi to ER but not ER
to Golgi membrane transport (Lippincott-Schwartz et al.,
1995). In contrast, several studies suggest that movement
of membranous organelles towards the centrosome is
driven by cytoplasmic dynein. The movement of the Golgi
elements towards the minus ends of microtubules has been
shown to require cytoplasmic dynein in semi-intact cells
(Corthésy-Theulaz et al., 1992). Injection of anti-DHC2
antibodies, a cytoplasmic dynein heavy chain predomi-
nantly localized on the ER-Golgi intermediate compart-
ment (Vaisberg, E.A., P.M. Grissom, S.R. Gill, T.A.
Schroer, and J.R. McIntosh. 1996. 
 
Mol
 
.
 
 Biol
 
.
 
 Cell
 
. 7:403a),
induced the dispersion of the Golgi complex (Vaisberg et
al., 1996). Overexpression of the dynamitin subunit of the
dynactin complex led to dispersion of the Golgi complex,
endosomes, and lysosomes (Burkhardt et al., 1997) and
blocked the ER to Golgi transport (Presley et al., 1997).
More recently, cDHC
 
2/2
 
 
 
blastocysts have been shown to
display a vesiculated Golgi complex, distributed through-
out the cytoplasm, although individual Golgi fragments
still attached to microtubules (Harada et al., 1998). A sim-
ilar effect was observed on endosomes and lysosomes dis-
tribution. These results indicate that molecules other than
cDHC might mediate attachment of the Golgi complex
and endosomes and lysosomes to microtubules.
Although the role of motors in these processes is now
well established, recent data argue that motors alone are
insufficient to mediate interactions of organelles with mi-
crotubules. Indeed, in studies where the static binding of
organelles to microtubules have been examined, binding
have been attributed to nonmotor proteins (Rickard and
Kreis, 1996). Comparison of the results obtained in these
studies revealed a number of differences suggesting that
there are specific nonmotor microtubule-associated pro-
teins for different organelles, that have been named
cytoplasmic linker proteins (CLIPs)
 
1
 
. The only CLIP ex-
tensively characterized to date is CLIP-170, a microtubule-
binding protein associating transiently with endosomes
during early to late endosome transport (Pierre et al.,
1992). Recently, it has been found that ch-TOG, the hu-
man homologue of XMAP-215, a previously described
microtubule-associated protein of 
 
Xenopus
 
 eggs, is as-
sociated to ER membranes in interphase human cells
(Charasse et al., 1998). In addition, p63, an integral mem-
brane protein of the reticular subdomain of the ER, has
been shown to bind microtubules in vivo and in vitro and it
could contribute to the positioning of the ER along micro-
tubules (Klopfenstein et al., 1998). A cytosolic factor of
150 kD responsible for phagosome-microtubule binding
has also been described (Blocker et al., 1996).
We have previously described a peripheral Golgi au-
toantigen of 210 kD whose localization is restricted to the
cis-Golgi network (CGN). Interestingly, this protein ex-
hibits an unusual behavior when cells are treated with no-
codazole (NZ) or Brefeldin-A. NZ induces a specific and
early segregation of many p210-associated vesicles or tu-
bules from the Golgi apparatus. Upon Brefeldin-A treat-
ment, p210 does not redistribute in the ER but exhibits a
vesicular pattern characteristic of proteins residing in the
CGN (Rios et al., 1994; Alcalde et al., 1994; Nakamura et
al., 1995). In this study we report isolation of the full-
length cDNA encoding p210. We show that this protein as-
sociates with the Golgi apparatus via its NH
 
2
 
 terminus and
directly interacts with microtubules through its COOH-
terminal domain. For these reasons, we have designated it
GMAP-210 (Golgi microtubule-associated protein 210).
Functional analyses of intact and mutant forms indicate
that GMAP-210 is a minus end microtubule-binding pro-
tein that plays a role in maintaining the structural integrity
of the Golgi apparatus.
 
Materials and Methods
 
Cell Culture and Antibodies
 
HeLa and COS-7 cells were grown under standard conditions. IgG frac-
tion (10 mg/ml final concentration) from RM autoimmune serum (AS)
and affinity-purified anti–GMAP-210 antibodies were obtained as de-
scribed in Rios et al. (1994). CTR433, a mouse monoclonal antibody, is a
marker of medial-Golgi (Jasmin et al., 1989). Polyclonal antibody anti–
 
g
 
-tubulin has been previously characterized (Tassin et al., 1998). Anti-
detyrosinated tubulin (
 
a
 
T12 and SG) and anti-p115 antibodies were sup-
plied by Drs. Kreis, Bulinski, and Sztul, respectively.
 
Molecular Cloning and Sequencing of GMAP-210
 
10
 
6
 
 recombinants of a 
 
l
 
ZAPII human HeLa cell random-primed cDNA
expression library (P. Chambon, IGBMC, Universitè Louis Pasteur, Stras-
boug, France) were screened with the autoimmune serum diluted 1:1,500
followed by anti–human IgG alkaline phosphatase conjugated (Promega
Corp.), and positive plaques were detected by incubation with BCIP and
NBT. Positive clones were plaque purified through several rounds of re-
screening. Affinity-purified antibodies against each of the three major au-
toantigens recognized by the serum (Rios et al., 1994) were obtained and
used to group the clones obtained in immunologically related families.
pBluescript phagemid containing the cloned cDNA inserts were excised
from 
 
l
 
ZAPII by coinfection with R408 helper phage as described in the
manufacturer’s instructions (Stratagene). The 3
 
9
 
 end of GMAP-210 was
cloned by RT-PCR. HeLa mRNA was prepared with a Quick prep
mRNA purification kit (Pharmacia Biotech). First-strand cDNA synthesis
was performed with an oligo-(dT) primer by using a First-strand cDNA
synthesis kit (Pharmacia Biotech). The completed first-strand reaction
was amplified directly by PCR with specific primers. Clone RT-10, con-
taining the 3
 
9
 
 end of GMAP-210 cDNA, was obtained with the primers P1
and P2 as indicated in Fig. 1 A.
A series of overlapping restriction fragments from the clones obtained
by immunoscreening were subcloned into pBluescript SK or pTZ19R.
Double-stranded cDNA in pBluescript or pTZ19R was sequenced on
both strands with an automatic sequencer (Pharmacia) by the dideoxy ter-
mination method (Sanger et al., 1977). Sequence data were compiled and
analyzed using the University of Wisconsin Genetics Computer Group
package version 8.1 for Unix computers and the EGCG extensions to the
Wisconsin package version 8.1.0. Comparisons to known sequences were
performed using tFASTA and BLAST. Primary and secondary structure
analysis was conducted with Motifs, PeptideStructure, PepStats, and Pep-
Coil.
The full-length open reading frame of GMAP-210 was assembled in the
eukaryotic expression vector pECE (Ellis et al., 1986) using clones R2,
R3, RT-7 (obtained by RT-PCR using primers P3 and P4), R6, and RT-10
(see Fig. 1 A). To obtain an HA epitope-tagged GMAP-210 protein, prim-
ers P5 and P6 were used to create an EcoRI site in the appropriate frame
for cloning into pECE-HA. GMAP-210 cDNA fragments coding for
amino acids 1–375 (
 
D
 
C375) and 1,778–1,979 (
 
D
 
N1778) were cloned in fu-
sion with the green fluorescent protein (GFP) into the eukaryotic expres-
sion vectors pEGFPN1 and pEGFPC1, respectively. Full-length or partial
GMAP-210 cDNAs were also cloned into the prokaryotic expression plas-
 
1. 
 
Abbreviations used in this paper:
 
 AS, autoimmune serum; CGN, cis-
Golgi network; CLIP, cytoplasmic linker protein; GFP, green fluorescent
protein; GMAP, Golgi microtubule-associated protein; GST, glu-
tathione-
 
S
 
-transferase; HSS, high speed supernatant; IB, immunoblotting;
IF, immunofluorescence; NZ, nocodazole.
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mids pGEX. The synthesis of the glutathione-
 
S
 
-transferase (GST) fusion
proteins was induced by addition of 1 mM isopropyl-
 
b
 
-
 
D
 
-thiogalactoside
and the fusion proteins were isolated from bacterial lysates by affinity
chromatography with glutathione-agarose beads (Sigma).
 
Northern Blot Analysis
 
Northern analysis was performed on poly(A)
 
1
 
 
 
RNA from human tissues
(commercial multiple Northern blot; Clontech). DNA fragments corre-
sponding to nucleotides 418–1,130 and 5,364-5,800 were radiolabeled and
used as probes.
 
Production of Polyclonal Antibodies
 
After cloning DNA fragments coding for amino acids 375–611 or 618–803
into pGEX vectors, GST-fusion polypeptides were expressed and purified
as described above. Fusion proteins were dialyzed in PBS and two rabbit
polyclonal antibodies were generated (Agrobio). Sera were collected and
Ig fraction purified by ammonium sulfate precipitation. These anti–
GMAP-210 polyclonal antibodies were named RM127 and RM130.
 
Electrophoresis, Immunoblotting,
and Immunoprecipitation
 
Gel electrophoresis and immunoblotting (IB) were performed as de-
scribed (Rios et al., 1994). For immunoprecipitation experiments, HeLa
cells were incubated for 30 min on ice in order to depolymerize microtu-
bules and then treated with 50 mM Tris-HCl, 150 mM NaCl, 1% NP-40
containing protease inhibitors. Soluble fraction was clarified at 15,000 
 
g
 
for 15 min and preadsorbed with 5 
 
m
 
l of normal human serum or 5 
 
m
 
l of
each preimmune rabbit sera on 100 
 
m
 
l of protein A–Sepharose. GMAP-
210 was immunoprecipitated from supernatants with 5 
 
m
 
l AS, 5 
 
m
 
l RM127,
or 5 
 
m
 
l RM130 on 100 
 
m
 
l of protein A–Sepharose. After incubation and
washing, the presence of GMAP-210 in the bead pellets was detected by
IB with RM130 polyclonal antibody.
 
Preparation of Microtubule-binding Proteins from 
HeLa Cells
 
2 
 
3
 
 10
 
8
 
 HeLa cells were trypsinized and harvested at 500 
 
g
 
 for 10 min at
room temperature. Subcellular fractionation in order to obtain a high
speed supernatant (HSS) was carried out as described by Rickard and
Kreis (1990). The protein concentration of the HSSs obtained ranged be-
tween 6–8 mg/ml when measured using the Bradford assay. The HSS was
adjusted at 3–4 mg/ml with PEM buffer (0.1 M K-Pipes, 2 mM EGTA, 1
mM MgSO
 
4
 
, pH 6.8), incubated for 30 min on ice and then incubated for
15 min at 37
 
8
 
C in the presence of 10 
 
m
 
M Taxol™ (Paclitaxel), 1 mM DTT,
and 1 mM GTP. Microtubules were centrifuged at 30,000 
 
g
 
 for 30 min at
30
 
8
 
C through a cushion of 10% sucrose in PEM containing 10 
 
m
 
M taxol, 1
mM DTT, and 1 mM GTP. Microtubules were washed and resuspended in
the same buffer (0.1–0.05 times the original HSS volume). Proteins were
eluted from the microtubules by adding 10 mM ATP, 10 mM GTP, 0.5 M
NaCl, or 2 M urea, respectively, and incubation at 37
 
8
 
C for 30 min fol-
lowed by centrifugation.
 
In Vitro Microtubule Binding Assays with Endogenous 
GMAP-210 or with GST-Fusion Polypeptides
 
Tubulin was purified from bovine brain by two cycles of polymerization
followed by chromatography on phosphocellulose. 10–20 
 
m
 
g of pure tubu-
lin/assay were polymerized with 20 
 
m
 
M taxol, 1 mM GTP, and 1 mM DTT
for 15 min at 37
 
8
 
C. Microtubules were centrifuged through 10% sucrose,
washed, and finally resuspended in PEM containing GTP and taxol.
After cloning different DNA fragments into pGEX vectors, GST-
fusion polypeptides were expressed and isolated from bacterial lysates by
affinity chromatography with glutathione-agarose beads. Microtubules
were then added to glutathione-agarose beads linked to similar amounts
of GST alone, GST-fusion polypeptides or GST-GMAP-210 (
 
,
 
0.5 
 
m
 
g).
After incubation for 2 h at room temperature, beads were low speed sedi-
mented (1,000 
 
g
 
) and washed in PEM buffer. The presence of microtu-
bules in the bead pellets was detected with anti–
 
a
 
-tubulin antibodies. Al-
ternatively, GMAP-210 was immunoprecipitated from HeLa cells NP-40
supernatants using 5 
 
m
 
l AS, 5 
 
m
 
l RM127, or 5 
 
m
 
l RM130 coupled to 100 
 
m
 
l
of protein A–Sepharose as described in a previous section. After washing,
 
beads were incubated for 2 h at room temperature with taxol-polymerized
microtubules. Then, beads were low speed sedimented (1,000 
 
g
 
) and
washed in PEM buffer. The presence of microtubules in the bead pellets
was detected with anti–
 
a
 
-tubulin antibodies.
 
Identification of Microtubule-associated Proteins by 
Selective Extraction of Cultured Cells
 
HeLa cells were incubated with 10 
 
m
 
M NZ or 10 
 
m
 
M taxol for 4 h at 37
 
8
 
C.
Untreated, NZ- or taxol-treated HeLa cells were washed twice with PBS
at room temperature and once with a microtubule-stabilizing buffer
PM2G (0.1 M K-Pipes, 2 M glycerol, 5 mM MgCl
 
2
 
, and 2 mM EGTA, pH
6.9). Then, washed cells were extracted for 5 min at room temperature
with 0.1–0.3% NP-40 in the same buffer to obtain NP-40 soluble fractions
(fraction S). The detergent-extracted preparations, that remained at-
tached to substrate, were washed with PM2G without detergent and incu-
bated for 30 min at 4
 
8
 
C in the same buffer containing 5 mM CaCl
 
2
 
 to
depolymerize microtubules (fraction Ca). The detergent and calcium-
insoluble preparations were also harvested (fraction I) and all fractions
obtained analyzed by SDS-PAGE and IB. All buffers contained protease
inhibitors (1 mM PMSF and 1 
 
m
 
g/ml each of aprotinin, pepstatin, chymo-
statin, and leupeptin). In the case of cells pretreated with drugs, each of
the washes contained the same concentration of the drug. In parallel,
HeLa cells grown on coverslips were treated and successively extracted
with NP-40 and calcium as described above. Cell ghosts were then pro-
cessed for immunofluorescence. The presence of microtubules was re-
vealed by using an anti–
 
a
 
-tubulin antibody.
 
Binding of GMAP-210 Constructs to Golgi Membranes
 
Fractions enriched in Golgi membranes were isolated from HeLa cells by
flotation in a sucrose gradient as described (Rios et al., 1994). Before fur-
ther processing, Golgi-enriched fractions were diluted by addition of sev-
eral volumes of 10 mM Tris-HCl, pH 7.4 and protease inhibitors were
added. The suspensions were then centrifuged at 200,000 
 
g
 
 for 2 h at 4
 
8
 
C.
To obtain GMAP-210–depleted Golgi membranes, membrane pellets
were incubated with 2 M NaCl for 30 min on ice, high speed centrifuged,
and finally resuspended in 10 mM Tris-HCl, pH 7.4, containing 250 mM
sucrose. GST-fusion polypeptides were purified on glutathione-agarose
beads. Preliminary experiments suggested that the presence of GST in the
NH
 
2
 
 terminus of the fusion proteins could decrease the association of the
recombinant proteins to membranes. Therefore, polypeptides were re-
leased from the fusion proteins by treatment with 1% thrombin (wt/wt).
Full-length GMAP-210 and 
 
D
 
N1597 construct could not be tested because
they were degraded by thrombin treatment. Binding to Golgi membranes
was performed using 10 
 
m
 
g of Golgi membranes and 
 
,
 
0.2 
 
m
 
g of each re-
combinant polypeptide. Since binding of GMAP-210 to membranes was
shown to resist 0.5 M NaCl we performed the binding assay in the presence
of this salt concentration. After sedimentation of Golgi membranes, binding
of the recombinant polypeptides was detected by IB using the AS. In the
absence of Golgi membranes, any recombinant polypeptide sedimented.
 
Transient Transfection and
Immunofluorescence Microscopy
 
Plasmid DNA used for transfection was purified through two preparative
CsCl/ethidium bromide equilibrium gradients, followed by phenol extrac-
tion and ethanol precipitation. COS cells were split 24 h before transfec-
tion so that they were 60–80% confluent on the day of transfection. 2–5 
 
3
 
10
 
6
 
 cells/assay were resuspended in 200 
 
m
 
l of 15 mM Hepes-buffered se-
rum-containing medium, mixed with 50 
 
m
 
l 210 mM NaCl containing 5–20
 
m
 
g plasmid DNA and electroporated using a Bio-Rad Gene Pulser. 6 h af-
ter electroporation, medium was replaced by fresh medium and cells were
processed for immunofluorescence (IF) staining after 24–48 h. Indirect IF
was carried out as described (Rios et al., 1994). For GFP-fluorescence,
cells were fixed in 
 
2
 
30ºC methanol for 3 min. The samples were observed
either using a Leica microscope and a Hamamatsu chilled CCD camera or
using a TCS4D confocal laser scanning microscope based on a DM micro-
scope interfaced with an Argon/Krypton laser. Simultaneous double fluo-
rescence acquisitions were performed using the 488-nm and the 568-nm
laser lines to excite FITC and TRITC dyes using a 63
 
3
 
 or 100
 
3
 
 oil immer-
sion PlanApo objectives. Images were transferred to a Macintosh com-
puter for editing. All documents presented except Fig. 8 (CCD images)
are two-dimensional projections of images collected at all relevant z-axes.
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In Vitro Microtubule Cosedimentation Assay
 
Microtubules were assembled in vitro from phosphocellulose-purified bo-
vine brain tubulin as described above. To generate more polymer ends
while keeping the polymer mass constant, microtubules were sheared by
repetitively passing them through a 26-gauge hypodermic needle attached
to 1-ml insulin syringe.
HeLa cells were incubated with 20 
 
m
 
M taxol for 4 h at 37
 
8
 
C and then
extracted with 1% NP-40 in PEM buffer. NP-40 soluble fraction from
taxol-treated cells (fraction TS) contained a pool of GMAP-210 and
 
g
 
-tubulin but no 
 
a
 
-tubulin as revealed by IB (see Fig. 12, top). Identical
amounts of TS fraction were mixed with equal amounts of microtubules
before (
 
2
 
) or after (
 
1
 
) shearing, incubated for 30 min at room tempera-
ture and then centrifuged through a 10% sucrose cushion at 60,000 
 
g
 
 for
30 min at 4
 
8
 
C. TS fraction and microtubule pellets were analyzed by IB for
the presence of GMAP-210, 
 
a
 
-tubulin and 
 
g
 
-tubulin.
 
Results
 
cDNA Cloning and Sequence Analysis of GMAP-210
 
cDNA clones for GMAP-210 (Fig. 1 A) were obtained af-
ter immunoscreening of a HeLa cDNA library with the
AS (clones R1–R6 and R8) and rescreening with an R8
fragment as a probe (clone R9). Clones were routinely ex-
pressed in fusion with GST and analyzed by IB using affin-
ity-purified anti–GMAP-210 antibodies. Sequence analy-
sis revealed that the 3
 
9
 
 end was missing but a sequence
database search detected several expressed sequence tags
whose 5
 
9
 
 ends were identical to the 3
 
9
 
 end of R9. Clone
RT-10, containing the stop codon and the polyadenylation
signal, was obtained by RT-PCR using primers P1 and P2
(from the partial cDNA sequence L40380; Lee et al.,
1995). This clone showed a very weak positive reaction in
blots revealed with affinity-purified anti–GMAP-210 anti-
bodies, explaining why the 3
 
9
 
 end of the protein was not
obtained by screening of the cDNA library with the AS.
The combined sequence derived from the overlapping
clones R2, R3, R5, R6, and RT-10 comprises a total of
6452 bp and contains an open reading frame of 5,937 bp.
The predicted protein sequence consists of 1,979 amino
acid residues (Fig. 1 B) and has a calculated molecular
mass of 223,902 and a predicted pI of 5.1, consistent with
the molecular weight and pI of GMAP-210 determined by
one- and two-dimensional gel electrophoresis (Rios et al.,
1994). The PROSITE Dictionary of Proteins Sites and
Patterns revealed multiple consensus motifs for phosphor-
ylation and two leucine zipper patterns between amino
acids 413–448 and 1,440–1,461. No known consensus nu-
cleotide-binding motifs were found consistent with the
lack of a direct effect of ATP or GTP on the binding of
GMAP-210 to microtubules.
Analysis of GMAP-210 amino acid sequence with Pep-
Coil program showed that a significant portion of the pro-
tein had a high probability of forming an extended coil
(Fig. 1, B and C). The secondary structure and charge dis-
play of GMAP-210 was predicted using the programs Pep-
tideStructure and PepStats. According to this analysis,
GMAP-210 appears as a very long coil encompassing most
of the sequence although interrupted by a 100–amino acid
stretch poorly structured and slightly basic. The NH
 
2
 
 ter-
minus is highly acidic and contains a small coiled-coil do-
main whereas the COOH terminus is a highly basic pro-
line and glycine-rich domain (Fig. 1, B and C). The two
longest coils are interrupted by two short segments that
Figure 1. (A) Restriction map of the full-length GMAP-210
cDNA clone. Schematic representation of the cDNA clones ob-
tained from a HeLa random-primed cDNA library (R1–R6, R8,
and R9) and RT-7 and RT-10 clones obtained by RT-PCR. The
full-length construct was assembled using clones R2, R3, R6, RT-7,
and RT-10. The restriction map of GMAP-210 cDNA is repre-
sented at the top; the stippled region corresponds to the open
reading frame. (B) Deduced amino acid sequence of GMAP-210.
Regions predicted to form coiled-coil structures are in italics and
boldface. Fragments used to generate polyclonal antibodies ap-
pear underlined. Proline residues disrupting coiled-coil are out-
lined. These sequence data are available from EMBL/GenBank
under accession number Y12490. (C) Schematic representation
of the secondary structure of GMAP-210. The data suggest an ex-
tended coiled-coil domain (boxes) interrupted by a non coiled-
coil region of 100 amino acids and surrounded by a highly acidic
NH2-terminal region containing a small coiled-coil domain and a
basic proline/glycine-rich COOH terminus. Isoelectric points of
the different regions are indicated at the top. LZ, leucine zipper;
PP, proline-containing sequence.
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contain proline residues. Since proline usually disrupts an
 
a
 
-helix, GMAP-210 seems to be organized into five coiled-
coil segments that are separated by non-helical linkers
(Fig. 1, B and C). The presence of two leucine-zippers
each localized in a long coiled-coil domain, further sup-
ports the possibility of an oligomeric form for GMAP-210
in vivo. Finally, the high content in proline and glycine
(19%) in the basic COOH-terminal domain suggests a
globular structure for this portion of the protein.
Potential protein sequence similarities between GMAP-
210 and known proteins were analyzed by searching the
GenBank and SwissProt data libraries using tFASTA and
BLAST. 20% identity of amino acid sequence was found
between GMAP-210 sequence predicted to be coiled-coil
and several structural and motor proteins of the cytoskele-
ton that contain coiled-coil domains such as CENP-E and
CENP-F, NuMA, CLIP-170, myosin heavy chains, kine-
sins and dyneins, and the yeast proteins Nuf1, Uso1p, and
Cut14. Comparison of GMAP-210 sequence with those of
previously reported Golgi autoantigens such as p230 (gol-
gin 245), GM130 (golgin 95), or GCP170 (golgin 160) re-
vealed no significant similarity (18% through coiled-coil
regions).
The tissue expression pattern of GMAP-210 mRNA was
studied by Northern blot analysis using two clones as
probes, corresponding to 5
 
9
 
 and 3
 
9
 
 ends. Both probes re-
vealed a single transcript of 
 
.
 
7 kb that was more abun-
dant in testis, heart, placenta, skeletal muscle and pancreas
although it could be also detected in other tissues (not
shown). The size of revealed mRNA easily exceeds that
required to encode a protein of 223 kD, supporting that
the isolated cDNA codes for GMAP-210.
To definitively demonstrate that the cDNA sequence
corresponded to that of the p210 autoantigen, we have
generated two polyclonal antibodies against two GST-
fusion proteins containing distinct regions of GMAP-210
(amino acids 375–611 and 618–803; Fig. 1 B). These poly-
clonal antibodies, named RM127 and RM130, revealed by
IB a band of identical electrophoretic mobility as that rec-
ognized by the AS (Fig. 2 A) and decorated the Golgi ap-
paratus by IF (see Figs. 7–11). Most importantly, GMAP-
210 was immunoprecipitated from PNS fractions of HeLa
cells using the AS, RM130, and RM127 antibodies and
immunoprecipitates were further analyzed by IB using
RM130 polyclonal antibody. As expected GMAP-210 was
detected in all cases (Fig. 2 B), clearly demonstrating that
the isolated cDNA encodes GMAP-210.
 
GMAP-210 Is a Microtubule-binding Protein
 
The first indication that GMAP-210 could be a microtu-
bule-binding protein came from its behavior during cell
treatment with microtubule-active drugs (Fig. 3 A). In un-
treated HeLa cells, GMAP-210 distributed in both Triton
X-100 soluble and insoluble fractions matching the distri-
bution of tubulin in these fractions. In taxol-treated cells,
all tubulin became insoluble whereas it was still possible to
detect part of GMAP-210 in the soluble fraction. Finally,
prolonged treatment of HeLa cells with NZ induced com-
plete depolymerization of tubulin and concomitantly com-
plete solubilization of GMAP-210. As a control, distribu-
tion of actin was analyzed and as expected, remained
unchanged under all of these treatments.
The association of GMAP-210 with microtubules was
further analyzed in vitro. We investigated whether GMAP-
210 cosedimented with microtubules purified from HeLa
cells using taxol. A post-nuclear supernatant was prepared
and centrifuged at high speed in order to obtain a super-
natant depleted of most of membrane organelles. This
high speed supernatant (HSS), that contained a pool of
GMAP-210 (Fig. 3 B), was incubated with taxol to poly-
merize endogenous tubulin. Microtubules were further
purified by sedimentation through a sucrose cushion.
GMAP-210 cosedimented with microtubules as revealed
by IB using the AS (Fig. 3 B). When HeLa cytosol was in-
cubated instead with NZ to prevent tubulin polymeriza-
tion, neither tubulin nor GMAP-210 sedimented through
the sucrose cushion, indicating that GMAP-210 sedimen-
tation was microtubule-dependent (not shown). To inves-
tigate the microtubule-binding characteristics of GMAP-
210, taxol-polymerized microtubules were incubated with
0.5 M NaCl, 10 mM ATP, or 10 mM GTP, centrifuged
through sucrose, and then the supernatants and pellets an-
alyzed for the presence of GMAP-210 by IB (Fig. 3 C).
Under all these conditions GMAP-210 was detected in
the microtubule-containing pellet. Similar results were
obtained when these agents were added to cytosol be-
fore incubation with taxol in order to prevent the associ-
ation (not shown). Only when 2 M urea was added to
taxol-polymerized microtubules, could GMAP-210 be
detected in the supernatant but, in these conditions, ap-
proximately half of tubulin was unpolymerized (Fig. 3
Figure 2. Isolated cDNA codes for GMAP-210. Two polyclonal
antibodies, named RM127 and RM130, were generated by immu-
nizing rabbits with GST-D375-611 and GST-D618-803 fusion pro-
teins. (A) These antibodies, the preimmune sera, and AS were
assayed on blots of HeLa fractions. RM127 and RM130 revealed
a band of identical electrophoretic mobility as that recognized by
the AS that was absent from blots incubated with preimmune
sera. (B) Endogenous GMAP-210 was immunoprecipitated from
HeLa cells extracts using AS, RM127 or RM130 polyclonal anti-
bodies linked to protein A–Sepharose beads. Immunoprecipi-
tates were then analyzed by SDS-PAGE and IB with RM130
polyclonal antibody. Preimmune serum was included as a con-
trol.
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C). From these experiments, we conclude that GMAP-
210 binds tightly to microtubules in vitro, in a nucleotide-
insensitive manner.
 
GMAP-210 Binds Directly to Microtubules via Its 
COOH-terminal Domain
 
To determine whether GMAP-210 binding to microtu-
bules is direct and to decide which domain(s) is responsi-
ble for this interaction, a panel of GST-fusion proteins
containing different portions of GMAP-210 or the com-
plete protein was prepared (Fig. 4 A, top) and immobi-
lized on glutathione-agarose beads. The immobilized
proteins were allowed to interact with microtubules as-
sembled from bovine brain phosphocellulose-tubulin with
taxol. The presence of microtubules bound to wild-type or
mutant proteins was detected by IB using an anti–
 
a
 
-tubu-
lin antibody (Fig. 4 A, bottom). These experiments dem-
onstrated a direct binding of GMAP-210 to microtubules
and further established that the microtubule binding
site(s) corresponded to the region containing amino acids
1,712–1,979, the basic COOH-terminal domain.
A similar experiment was then carried out but endoge-
nous GMAP-210 was used instead of recombinant GST–
GMAP-210 fusion protein. GMAP-210 was immunopre-
cipitated from HeLa cell lysates using AS, RM127, or
RM130 antibodies precoupled to Sepharose beads. Beads
were then incubated with microtubules assembled from
bovine phosphocellulose-tubulin with taxol. Fig. 4 B shows
that endogenous GMAP-210 efficiently interacted with
microtubules. In the absence of added microtubules,
no tubulin was detected (RM130-Mts) indicating that
GMAP-210 did not bind soluble tubulin present in the cell
lysates.
 
GMAP-210 Associates Preferentially with a 
Subpopulation of Stable Microtubules
 
To further characterize the association of GMAP-210 with
microtubules in situ, we analyzed the microtubular cyto-
skeleton by selective extraction of cells (Solomon, 1986;
Fig. 5). To do so, untreated (Control), 10 
 
m
 
M NZ-, or 10 
 
m
 
M
taxol-treated cells were permeabilized with a non-ionic de-
tergent in order to extract cytoplasmic proteins (fraction
S). Then, microtubules were depolymerized and extracted
with a cold-calcium–containing buffer (fraction Ca). All
fractions obtained together with the detergent- and cal-
cium-insoluble fractions (fraction I) were processed by IB
to analyze the distribution of tubulin and GMAP-210. Fig.
5 A shows that, unexpectedly, tubulin was present in de-
tergent- and calcium-insoluble fractions corresponding to
control and taxol-treated cells. This result suggested that a
subpopulation of microtubules could resist the depolymer-
ization induced by cold-calcium. To confirm this assump-
tion, untreated-, NZ-, and taxol-treated cells were ex-
tracted with NP-40 and cold-calcium. Cell ghosts were
then processed for IF and labeled with an anti–
 
a
 
-tubulin
monoclonal antibody (Fig. 5 B). According to biochemical
data, some microtubules growing from the centrosome
could be observed in untreated cells and no microtubules
were present in NZ-treated cells whereas many microtu-
bules resisted extraction in taxol-treated cells. GMAP-210
was absent from all Ca-soluble fractions but present in
insoluble fractions corresponding to control and taxol-
treated cells (Fig. 5 A). This result indicates that GMAP-
210 does not bind to all assembled microtubules in situ but
interacts preferentially with a subset of cold-calcium–resis-
tant microtubules. GMAP-210 was also detected in the
soluble fractions under all conditions suggesting that bind-
Figure 3. (A) Effects of microtubule-
active drugs on the distribution of
GMAP-210. HeLa cells were incu-
bated with culture medium alone
(Control), or with culture medium con-
taining 10 mM nocodazole or 10 mM
taxol for 4 h at 378C. Cells were then
extracted with 0.5% Triton in PHEM
buffer for 5 min. Soluble (S) and insol-
uble (I) fractions were immunoblotted
and blots probed with the AS, anti–
a-tubulin antibody and anti-actin anti-
body as a control. (B) GMAP-210
binds to taxol-polymerized microtu-
bules. HeLa cells were mechanically
homogenized and the homogenates
(H) were centrifuged at low speed to
obtain a nuclear pellet (NP) and a
post-nuclear supernatant (PNS). PNS
was centrifuged at high speed and the
supernatant (HSS) was incubated at
378C for 15 min in the presence of 10 mM taxol. Microtubules (MTs) were sedimented through a cushion of 10% sucrose and all these
subcellular fractions together with the microtubule-depleted supernatant (S) were then analyzed by SDS-PAGE and IB using AS and
an anti–a-tubulin antibody. (C) Taxol-stabilized microtubules from HeLa cells were incubated with 0.5 M NaCl, 10 mM ATP, 10 mM
GTP, and 2 M urea and equivalent amounts of supernatants (S) and pellets (P) analyzed by SDS-PAGE and IB for GMAP-210 and tu-
bulin.
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ing of GMAP-210 to microtubules in vivo must be regu-
lated since all GMAP-210 did not bind to microtubules
even when all tubulin became polymerized with taxol (see
also Fig. 3 A).
To characterize this subpopulation of stable microtu-
bules, we quantitatively analyzed the distribution of dety-
rosinated a-tubulin (glu-tubulin) with respect to total tu-
bulin (a-tubulin) in the three fractions obtained from
control cells, using the same subfractionation procedure
(S, Ca, and I; Fig. 5 C). In untreated cells, tubulin was
found to distribute as follows: 35% was soluble, 52% was
polymerized in microtubules that were sensible to cold-
calcium (corresponding to 80% of total microtubules), and
13% in microtubules resistant to these conditions (corre-
sponding to 20% of microtubules). This subpopulation of
more stable microtubules contained 29% of the total dety-
rosinated a-tubulin whereas 80% of more labile microtu-
bules contained 67% of glu-tubulin. These results indicate
that resistant microtubules contain 1.8 times more glu-
tubulin than the rest. Thus, GMAP-210 appears preferen-
tially associated in situ to a subpopulation of stable micro-
tubules that are enriched in detyrosinated a-tubulin.
GMAP-210 Associates with Golgi Membranes via Its 
Acidic NH2 Terminus
The binding site for Golgi membranes on GMAP-210 was
also mapped by deletion analysis. A series of NH2-ter-
minal and COOH-terminal truncation mutants were
constructed and expressed as GST-fusion proteins (Fig.
6, top). They were immobilized on glutathione-agarose
beads and further treated with thrombin to release recom-
binant proteins from GST. Golgi membranes were puri-
fied by flotation in a sucrose gradient, washed with 2 M
NaCl to remove endogenous GMAP-210 and centrifuged
at high speed. 10 mg of washed Golgi membranes were in-
cubated with ,0.2 mg of different fragments of GMAP-
210 in the presence of 0.5 M NaCl. After centrifugation,
both supernatants and pellets were analyzed by IB using
the AS (Fig. 6). The constructs DC611 and DC375 ap-
peared enriched in Golgi membranes containing pellets,
whereas fragments lacking NH2-terminal domain mostly
remained in supernatants. Binding of GMAP-210 NH2 ter-
minus to Golgi membranes was further confirmed in vivo
by transfection experiments (see below).
Functional Analysis of GMAP-210 In Vivo
To approach the function of GMAP-210 in the organiza-
tion of the Golgi apparatus, we transiently expressed in-
tact or mutant proteins in COS cells. Full-length cDNA
coding for GMAP-210 with or without an NH2-terminal
HA-epitope was introduced in cells by electroporation.
Cells were incubated, fixed, double labeled and finally ob-
served in a confocal laser microscope. An effect on the
structure of the Golgi apparatus and microtubule network
could be observed depending on the expression level of
the transfected protein. At low expression level, the full-
length GMAP-210 localized to a compact juxtanuclear
reticulum characteristic of the Golgi apparatus as revealed
by an anti-HA antibody (not shown). The labeling pattern
overlapped exactly with that exhibited by the AS that rec-
ognized both exogenous and endogenous proteins, indicat-
ing that the expressed protein is targeted to the same place
as the endogenous GMAP-210, namely the CGN. No sig-
nificant changes in the structure of the Golgi complex
or the microtubule network could be appreciated (not
shown).
By contrast, overexpression of GMAP-210 dramatically
perturbed the organization of the Golgi apparatus. Under
these conditions, transfected cells could be easily distin-
guished from the surrounding nontransfected cells by IF,
due to the high amount of exogenous GMAP-210. Several
features could be observed. First, a dramatic enlargement
of the Golgi apparatus that could remain as a single peri-
centrosomal structure (Fig. 7 a) or as multiple fragments
centrosomally localized but also distributed throughout
the cytoplasm (Fig. 7 d). Double labeling for GMAP-210
and the medial Golgi marker CTR433 (Jasmin et al., 1989;
Fig. 7, a–c) or the cis-Golgi marker p115 (Barroso et al.,
1995; Fig. 7, d–f) revealed that not only the CGN but also
Figure 4. GMAP-210 binds directly to microtubules via its
COOH-terminal domain. (A) Different portions of GMAP-210
or the complete protein were cloned in fusion with GST and im-
mobilized on glutathione-agarose beads. Pure bovine brain tubu-
lin was polymerized using taxol, microtubules were centrifuged
through sucrose, washed and resuspended in PEM buffer. Poly-
merized microtubules were added to beads linked to GST alone,
GST-fusion polypeptides, or GST-GMAP-210. After incubation
and washing, the presence of microtubules in the bead pellets was
revealed by IB using an anti–a-tubulin antibody. A summary of
results obtained is shown at the top. The clones expressed as
GST-fusions are represented as boxes. (B) Taxol-polymerized
microtubules (lane Mts) were added to AS (lane AS1Mts),
RM127 (lane RM1271Mts), and RM130 (lane RM1301Mts)
immunoprecipitates from HeLa extracts, incubated and finally
analyzed by SDS-PAGE and IB with anti–a-tubulin antibodies.
As controls, preimmune serum was used instead of the immune
sera (lane PI1Mts) or microtubules were not added (lane
RM1302Mts).
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the other compartments of the Golgi apparatus were dis-
torted by overexpression of GMAP-210. Remarkably, the
spatial distribution of GMAP-210 and the Golgi markers
was largely coincident, although they demonstrated a
graded inverse distribution: GMAP-210 labeling increased
towards the periphery whereas the intensity of CTR433
and p115 decreased. A careful analysis of optical cuts sug-
gested an hypertrophy of the CGN extending towards the
cell periphery whereas the remnant of the Golgi stacks re-
mained close to the nucleus (Fig. 7, c and f). Second, the
array of microtubules in the centrosomal area appeared
modified in overexpressing cells. The microtubule aster
became undefined and many microtubules appeared to
emanate from the enlarged Golgi area rather than from
the centrosome (Fig. 7, g–i). In overexpressing cells in
which the Golgi complex was fragmented, perturbation
was more pronounced and microtubules appeared ran-
domly distributed.
We further showed that the Golgi perturbation pro-
voked by GMAP-210 overexpression depended upon the
microtubule-binding capacity of the protein: when a trun-
cated form of GMAP-210 lacking the COOH-terminal mi-
crotubule-binding domain (DC1778) was overexpressed, it
clearly accumulated at the Golgi apparatus although an
Figure 5. GMAP-210 selec-
tively interacts with a sub-
population of stable micro-
tubules. (A) Untreated-,
nocodazole- or taxol-treated
HeLa cells were extracted
for 5 min with 0.3% NP-40
in a microtubule-stabilizing
buffer and the detergent-sol-
uble fractions obtained were
harvested (S fractions). Ex-
tracted cells were then incu-
bated for 30 min on ice in the
same buffer containing 5 mM
CaCl2 in order to depolymer-
ize microtubules (Ca frac-
tions). All fractions together
with the detergent- and cal-
cium-insoluble fractions (I)
were also analyzed by SDS-
PAGE and IB using the AS
and anti–a-tubulin antibod-
ies. (B) HeLa cells grown on
coverslips were treated and
successively extracted with
NP-40 and calcium as de-
scribed in A. Cell ghosts were then processed for IF. The presence of microtubules was revealed by using an anti–a-tubulin antibody.
Bars, 10 mm. (C) NP-40–soluble, CaCl2-soluble, and insoluble fractions from untreated HeLa cells were resolved by SDS-PAGE and
blotted. Two identical blots were incubated with anti–a-tubulin antibody or with SG, a polyclonal antibody against detyrosinated tubu-
lin (glu-tubulin). The same number of cells were used in each experiment, the different extractions were made in the same volume and
identical volumes of samples analyzed in each line of gels. Blots were quantitatively analyzed using a Bio-Rad densitometer. Values are
means of three independent experiments.
Figure 6. NH2-terminal domain of GMAP-210 mediates its asso-
ciation to Golgi membranes. Different regions of GMAP-210
were expressed in fusion with GST and purified on glutathione-
agarose beads. Beads were treated with thrombin to release re-
combinant polypeptides. Golgi membranes were purified by flo-
tation in a sucrose gradient, washed with 2 M NaCl and centri-
fuged. 10 mg of Golgi membranes was incubated with ,0.2 mg of
recombinant polypeptides, centrifuged, and then supernatants
and pellets were analyzed by IB using the AS. It must be noted
that not all fragments were recognized with identical affinity by
the AS. A summary of results obtained is shown at the top. The
clones tested in the binding assay are represented as boxes.
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homogeneous cytoplasmic staining was also observed (Fig.
8, a–c). Comparison between a DC1778 overexpressing
cell (Fig. 8, d, f, and h) and a nontransfected cell (Fig. 8, e,
g, and i) revealed no significant differences in the Golgi
apparatus or the microtubule network structure. It must
be noted that overexpression of this mutant had no detect-
able effect on the distribution of endogenous GMAP-210.
We also studied the effect of microtubule-active drugs
on the phenotype displayed by GMAP-210 overexpres-
sing cells. When transfected cells were incubated with NZ,
the Golgi apparatus became fragmented and scattered
throughout the cytoplasm in all overexpressing cells and
complete colocalization with CTR433 and p115 was ob-
served (not shown). Transfected cells were also incubated
with taxol to promote the formation of microtubule bun-
dles. In the presence of taxol, GMAP-210–enriched mem-
branes preferentially redistributed at the periphery of the
cells, whereas the rest of the Golgi complex remained jux-
tanuclear (Fig. 9, a–c). GMAP-210–enriched membranes
were found to be always located at one end of microtubule
bundles (Fig. 9, d–f). Higher magnifications at the cellular
periphery allowed to distinguish individual microtubules
and GMAP-210–enriched membranes could be seen asso-
ciated with them (Fig. 9, g–i). Thus, taxol-induced micro-
tubules were able to tear the GMAP-210–enriched ele-
ments away from the rest of the Golgi apparatus.
To further characterize the functional domains of
GMAP-210, both NH2-terminal and COOH-terminal do-
mains were cloned in fusion with the green fluorescent
protein and transiently expressed in COS cells. DC375-
GFP mutant appeared mostly cytosolic but also localized
in punctate structures clustered in the Golgi region (Fig.
10 a). Labeling with an antibody that specifically recog-
nized endogenous GMAP-210 revealed partial colocaliza-
tion (Fig. 10, a–c). This result indicated that the truncated
chimera was able to bind to Golgi membranes. At higher
expression level, endogenous GMAP-210 was hardly visi-
ble consistent with the truncated mutant displacing the en-
dogenous protein from membranes (Fig. 10, d–f). Under
these conditions, the medial Golgi marker CTR433 also
showed an altered distribution (Fig. 10, g–i). Instead of the
normal compact Golgi seen in the untransfected cell in this
field, CTR433 appeared in some punctate structures in the
Golgi area and the labeling intensity had considerably de-
creased. Therefore, Golgi compartments other than the
CGN appeared morphologically perturbed in the absence
of membrane-bound GMAP-210. These data together
with those presented in Fig. 6 demonstrate that the NH2
Figure 7. Localization and
effect of GMAP-210 overex-
pression on the Golgi appa-
ratus and the microtubule
network structure. Double
IF was performed with
RM130 (a, red) and CTR433
(b, green), or the AS (d, red)
and anti-p115 (e, green).
Separate red and green im-
ages were collected and over-
laid (c and f). Yellowish
staining indicates colocaliza-
tion of GMAP-210 enriched
membranes with the Golgi
apparatus. Cells were also
stained with RM130 (g, red)
and an anti-tubulin antibody
(h, green). Red and green
images were collected sepa-
rately and superposition of
the two labelings is shown
in i. Arrows in g and h in-
dicate the Golgi apparatus
and the microtubule aster in
nontransfected cells. Bars,
10 mm.
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terminus of GMAP-210 is involved in targeting the protein
to Golgi membranes and strongly suggest that GMAP-210
is required for processes involved in maintaining the integ-
rity of the Golgi apparatus.
Similar experiments were carried out with the microtu-
bule-binding domain for which GFP was placed in the
NH2 terminus of the mutant protein. Contrary to our ex-
pectations, the GFP-DN1778 mutant protein did not
Figure 8. Expression of a
GMAP-210 mutant form
lacking the microtubule-
binding site. After transfec-
tion, cells were fixed and
double labeled for GMAP-
210 (a) and the medial Golgi
marker CTR433 (b). Red
and green image pair is
shown in c. Arrow in b indi-
cates a nontransfected cell.
Alternatively, cells were
stained for GMAP-210 (d, e)
and a-tubulin (f, g) and im-
age pairs are shown in h and
i, respectively. In d, f, and h,
a transfected cell is shown. In
e, g, and i, a nontransfected
cell is presented for compari-
son. Bars, 10 mm.
Figure 9. Effect of taxol on
GMAP-210 overexpressing
cells. Transfected cells were
incubated with 10 mM taxol
for 4 h and double stained
for GMAP-210 (a, d, and g,
red) and CTR433 (b, green)
or tubulin (e and h, green).
Superpositions of labelings
are shown in c, f, and i. Pref-
erential redistribution of
GMAP-210–enriched mem-
branes was observed at the
cell periphery where the
staining for GMAP-210 was
equivalent to that observed
in a juxtanuclear location
(two opposed arrowheads in
a). In b, the two unequal ar-
rowheads indicate unequal
partitioning of a Golgi
marker that mostly remains
in a juxtanuclear location.
Note in f and i that GMAP-
210–enriched Golgi elements
are invariably associated
with one end of microtubule
bundles. Bars, 10 mm.
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decorate microtubules. At low expression level, one or
two spots that colocalized with the centrosomal marker
CTR453 (Bailly et al., 1989) could be observed (Fig. 11, a–c).
With increasing expression levels of the mutant, increasing
accumulation of GFP at the centrosome occurred together
with the dispersion of the pericentriolar material that be-
came almost undetectable with the monoclonal antibody
CTR453 (Fig. 11, a1–3, b1–3, and c1–3). Centrioles were
present in the center of the GFP-labeled centrosomes, as
revealed by anti-detyrosinated tubulin antibodies (not
shown). After longer periods of expression, GFP-DN1778
accumulated massively at the centrosome (Fig. 11, d–f) al-
though heterogeneous sized bright foci of GFP scattered
throughout the cytoplasm were also observed. The Golgi
apparatus was displaced to the periphery of the massive
centrosomal aggregate (Fig. 11, e and f) that appeared sur-
rounded by a dense network of detyrosinated microtu-
bules (Fig. 11, g–i).
GMAP-210 Binds to Microtubule Ends
The finding that the COOH-terminal microtubule-binding
domain of GMAP-210 localizes in vivo to centrosome
strongly suggested that GMAP-210 might interact only
with the minus ends of microtubules. One prediction of
this hypothesis is that for constant polymer mass, GMAP-
210 binding to microtubules in vitro will increase when
more ends are present. To test this, we sheared a constant
mass of microtubules (polymerized from phosphocellu-
lose-bovine brain tubulin using taxol) by passing them
through a hypodermic needle attached to 1-ml syringe. In
parallel, we prepared a NP-40 soluble fraction from HeLa
cells that had been treated with taxol for 4 h in order to
completely polymerize the endogenous tubulin. This tubu-
lin-free fraction (TS) contained a pool of GMAP-210 and
g-tubulin, as revealed by IB (Fig. 12, top). Equal amounts
of fraction TS were mixed with equal amounts of microtu-
bules before (2) or after (1) shearing. After incubation,
microtubules were centrifuged through a sucrose cushion
and microtubule-pellets analyzed by IB. A typical experi-
ment is shown in Fig. 12 (top) and the mean of values of
three independent experiments is represented in Fig. 12
(bottom). Shearing increased the number of microtubules
twice as determined by quantification of bound g-tubulin
before and after shearing. By using the same procedure Li
and Joshi (1995) obtained an increase in the microtubules
number of 1.5 times, fitting well with our results. The
amount of GMAP-210 bound to microtubules also in-
creased 1.8 times indicating that GMAP-210 interacts only
with the ends of microtubules.
Discussion
Significant progress has been made towards understanding
the molecular mechanisms of microtubule-dependent mo-
Figure 10. Transient expres-
sion of GFP-tagged NH2-ter-
minal domain of GMAP-210.
Cells were transfected with
DC375-GFP (a, d, and g,
green), processed and la-
beled with RM130 (b and e,
red) or CTR433 (h, red). A
nontransfected cell is shown
in b and h for comparison.
In c, f, and i superpositions
of labelings are shown. Bars,
10 mm.
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tors and their roles in membrane traffic. By contrast, the
possible role of other microtubule-binding proteins lack-
ing motor activity in the organization of the central mem-
brane system has remained elusive. We report here the
cloning and functional characterization of a previously de-
scribed CGN-associated protein, p210.
GMAP-210 Is a Large Coiled-Coil Protein that Binds to 
Microtubule Ends via Its COOH Terminus and to 
Membranes through Its NH2-terminal Domain
Several pieces of evidence argue for GMAP-210 being
a microtubule-binding protein. First, the presence of GMAP-
210 in Triton-extracted cell ghosts is always dependent
on the existence of polymerized microtubules. Second,
GMAP-210 cosediments with taxol-polymerized microtu-
bules from HeLa cells and remains associated in situ with
stable microtubules. Finally, both endogenous GMAP-210
and purified bacterially expressed GMAP-210 interact
with purified bovine brain microtubules. Interestingly,
GMAP-210 binding to microtubules increases with the
number of free ends in a given mass of microtubule poly-
mers. This was demonstrated by shearing microtubules
into short fragments, hence keeping the polymer mass
constant. Interaction of GMAP-210 with polymerized tu-
bulin appears to be a tight nucleotide-insensitive binding
as it is not released from the microtubule pellet by salt
conditions that are known to dissociate most MAPs, or by
ATP or GTP addition. These binding characteristics corre-
late well with those reported for interaction between the
Golgi complex and microtubules (Karecla and Kreis,
1992) and differ from those exhibited by CLIP-170, mo-
tors, or other MAPs.
The complete sequence of GMAP-210 has been ob-
tained (accession number Y12490). Recently, an almost
identical sequence, submitted to data banks after submis-
sion of our sequence, has been reported under the acces-
sion number AF007217 (Chang et al., 1997). This protein
was reported to be a thyroid hormone receptor coactiva-
tor, negatively regulated by the retinoblastoma protein
and named Trip230. We have no explanation for such a
functional discrepancy but we are confident that the se-
quence we have cloned corresponds to the p210 autoanti-
gen associated to the Golgi apparatus described previously
(Rios et al., 1994) by all the experimental data presented
in this paper. In addition, a partial cDNA sequence of
a novel gene named CEV-14 (these data are available
from GenBank/EMBL/DDBJ under accession number
Figure 11. Transient expres-
sion of GFP-tagged COOH-
terminal domain of GMAP-
210. Cells were transfected
with GFP-DN1778, pro-
cessed and labeled with dif-
ferent markers. (a–c) A low
magnification image show-
ing a GFP-DN1778 express-
ing cell surrounded by sev-
eral nontransfected cells (a,
green). After transfection,
cells were labeled with the
centrosomal marker CTR453
(b, red). In c, superposition
of both labelings is shown.
Note that no staining with
CTR453 could be detected in
the GFP–COOH-terminal
domain expressing cell. a1–3
(green) show increasing ex-
pression levels of GFP-
DN1778; b1–3 (red) show
staining with CTR453 and in
c1–3 superpositions of both la-
belings are shown. (d–f) Ef-
fect of overexpression of
GFP–COOH-terminal do-
main on the Golgi apparatus.
Image pairs of GFP-DN1778
(green) and RM130 (d and e,
red) or CTR433 (f, red) are
presented. (g–i) GFP-
DN1778 overexpressing cell
(g, green) labeled for detyro-
sinated tubulin (h, red). Im-
age pair is shown in i. Bars,
10 mm.
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AF011368) that corresponds to amino acids 1,188–1,753 of
GMAP-210 has been reported. This partial sequence has
been identified as the NH2-terminal half of a fusion gene
in which the COOH-terminal half is a fragment of the
platelet-derived growth factor receptor containing trans-
membrane and tyrosine kinase domains. CEV14-PDGFR
fusion gene is generated by a chromosomal translocation
that is associated with acute myelogenous leukemia (Abe
et al., 1997). Our finding that this fragment corresponds to
the second large coiled-coil domain of GMAP-210 sup-
ports the idea proposed by the authors that the mechanism
of transformation is the ligand-independent dimerization
of PDGFR leading to ectopic constitutive tyrosine kinase
activation.
Structural features predicted by the molecular charac-
terization of GMAP-210 indicate a long a-helical domain
with high potential to form a coiled-coil structure. Such a
long coiled-coil domain has been found in other autoanti-
gens associated with the cytoplasmic face of the Golgi
membrane including giantin or GCP372 (Seelig et al.,
1994; Sohda et al., 1994), golgin–245 or p230 (Fritzler et
al., 1995; Erlich et al., 1996), golgin–95 or GM130 (Frit-
zler et al., 1993; Nakamura et al., 1995), and golgin 160 or
GCP170 (Misumi et al., 1997).
GMAP-210 is distinct from previously described micro-
tubule-interacting proteins. GMAP-210 is predicted to
possess a three domain structure consisting of the long
a-helical central domain and the nonhelical end domains,
similar to other proteins that interact with the cytoskele-
ton. The organization of charged regions of GMAP-210 is
also reminiscent of that of several other MAPs. The NH2-
terminal end is acidic whereas the COOH-terminal do-
main has a high pI like MAP2 (Lewis et al., 1988), MAP4
(West et al., 1991), tau (Lee et al., 1988), or NuMA
(Compton et al., 1992). However, it is inverse to CLIP-170
that contains a basic NH2-terminal domain, a central
coiled-coil domain, and an acidic COOH-terminal domain.
The highly basic COOH-terminal region of GMAP-210
was shown to mediate direct interaction with microtu-
bules. Neither the acidic NH2-end, nor the long a-heli-
cal domain associate with microtubules in vitro. Thus,
GMAP-210 behaves like most MAPs characterized so far,
in which basic regions play a significant part in conferring
ability to bind microtubules. The microtubule-binding do-
main of GMAP-210 shows no overall homology to any of
previously characterized sites. It does not contain internal
repeats like MAP2, tau, or CLIP-170, suggesting that only
one binding site is present in each GMAP-210 molecule.
The binding domain of GMAP-210 to the cytoplasmic
side of CGN membranes has been localized in the NH2
terminus of GMAP-210. This region consists of two acidic
nonhelical regions interrupted by a small coiled-coil do-
main and followed by a large coil. The acidic COOH-ter-
minal domain of CLIP-170 has also been postulated to in-
teract with other proteins on the surface of endocytic
organelles. A molecular design consisting of an elongated
molecule containing a conserved microtubule-binding re-
gion at one end and a variable domain at the other end in-
volved in specifying interactions with organelles has been
proposed for nonmotor proteins implicated in linking cy-
toplasmic organelles to microtubules such as CLIP-170
(Pierre et al., 1992). Although no significant sequence ho-
mology with CLIP-170 out of the coiled-coil region has
been found, the molecular design of GMAP-210 fits well
with this model.
GMAP-210 Is Required for Processes Maintaining the 
Structural Integrity of the Golgi Apparatus
The biochemical data provide strong evidence that GMAP-
210 is a Golgi-associated protein that directly interacts
with microtubule ends. Consistent with this, overexpres-
sion of GMAP-210 induced perturbations in both the
Golgi apparatus and the microtubule network, and these
effects increased with the expression level of the protein.
Exogenous GMAP-210 was correctly addressed to the
Golgi apparatus that appeared dramatically enlarged and
sometimes fragmented in structures scattered throughout
Figure 12. Binding of GMAP-210 to microtubules depends on
the number rather than on the mass of microtubules. (Top) A
NP-40–soluble and tubulin-free fraction was obtained from HeLa
cells treated during 4 h with 20 mM taxol (fraction TS). This frac-
tion contained a pool of GMAP-210 and g-tubulin. Equal
amounts of fraction TS were mixed with equal amounts of a sus-
pension of taxol-induced microtubules from phosphocellulose-
tubulin, before (2) or after (1) shearing through a 26-gauge
hypodermic needle, and centrifuged through a sucrose cushion.
Microtubule pellets were analyzed by IB. Shearing microtubules
resulted in increased binding of g-tubulin, indicating that more
microtubule minus ends had been generated. Increased binding
of GMAP-210 was also observed. (Bottom) Blots corresponding
to three independent experiments were quantitatively analyzed
using a Bio-Rad densitometer and NIH Image software. Quanti-
fication analysis indicates a twofold increase of bound g-tubulin
to sheared microtubules. In parallel, bound GMAP-210 in-
creased 1.8 times.
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the cytoplasm. This hypertrophy of the Golgi apparatus
occurred together with a modification of the microtubule
network that mainly affected the Golgi-centrosome area.
In fact, transfected cells could be easily identified by look-
ing at the microtubule network, due to the absence of a
distinct microtubule aster at the centrosome. Instead, a
dense network of short microtubules could be appreciated
colocalizing with the enlarged Golgi apparatus, and cyto-
plasmic microtubules seemed to emanate from the periph-
ery of this perturbed region. Deletion of the COOH-ter-
minal domain completely abolished both effects, strongly
suggesting that the basic COOH terminus is responsible
for binding of GMAP-210 to microtubules in vivo as well
as in vitro. These data also indicate that the perturbation
of the Golgi apparatus produced by GMAP-210 overex-
pression is primarily due to an excess of binding to micro-
tubules.
It was intriguing that truncated GMAP-210 lacking mi-
crotubule-binding domain (DC1778) accumulated mostly
in the cytosol whereas intact GMAP-210 associated almost
completely with Golgi membranes. The DC1778 mutant
partially associated with Golgi membranes without appar-
ently displacing endogenous GMAP-210, suggesting that
endogenous GMAP-210 is present at subsaturating levels
in cells and that interaction of GMAP-210 with mem-
branes is saturable. This view is also consistent with the re-
sults obtained in vitro in which purified GMAP-210–con-
taining membranes were able to bind a limited amount of
DC611 or DC375 mutants. But how to understand that
GMAP-210 can steadily accumulate on CGN membranes
in cells overexpressing the full-length protein if the inter-
action of GMAP-210 with CGN membranes is saturable?
An amplification mechanism could reasonably explain this
paradoxical observation: the progressive accumulation of
GMAP-210 to the CGN would induce the stabilization of
microtubules in this area that would allow the progressive
enlargement of CGN elements. Such an increase in mem-
brane surface would in turn allow that more GMAP-210
accumulates.
Numerous observations indicate that the size of the
Golgi apparatus is maintained by a fine tuning of the
membrane flux in and out of the Golgi complex. Overex-
pression of GMAP-210 produces a significant increase in
the Golgi apparatus size. On the contrary, when endoge-
nous GMAP-210 is displaced from Golgi membranes by
overexpression of a truncated mutant containing only the
membrane binding domain, the size of the Golgi complex
decreased (DC375; see Fig. 10). Thus, GMAP-210 seems
to play a role in determining the size of the Golgi ap-
paratus, probably by regulating the number of microtu-
bule-binding sites on the surface of the CGN. A tighter as-
sociation of the CGN with microtubules could prevent its
maturation into Golgi cisternae (Bannykh and Balch,
1997) or impede anterograde vesicular transport from the
CGN to the medial Golgi (Orci et al., 1997), producing the
enlargement of the CGN by accumulation of newly syn-
thesized or recycling proteins. This could explain the par-
tial colocalization of cis- and medial-Golgi markers with
GMAP-210 in the enlarged CGN. At higher expression
levels, translocation of pre-Golgi elements from periph-
eral ER sites to the Golgi area could be also affected and
fragmentation of the enlarged Golgi apparatus would oc-
cur. Consistent with this, microtubules appeared randomly
nucleated in cells in which the Golgi apparatus was frag-
mented.
The relationship between CGN and microtubules thus
appears as a finely regulated interaction in order to ensure
not only the localization but also the steady state structure
and size of the Golgi apparatus. Many recent studies have
emphasized the role of microtubule motors not only in
membrane traffic but also in determining the localization
and morphology of the Golgi apparatus. It has been pro-
posed that in the steady state the Golgi complex is in dy-
namic equilibrium between the anterograde force medi-
ated by kinesin family motors and the retrograde force
mediated by cytoplasmic dyneins rather than simply be-
ing associated with microtubules near their minus end
(Harada et al., 1998). Our results indicate that association
of CGN membranes with the minus end of microtubules is
also necessary for the proper localization, morphology and
size of the Golgi apparatus. They are consistent with a
model in which dynein is responsible for moving Golgi ele-
ments towards the centrosome whereas GMAP-210 is reg-
ulating the static binding of the Golgi membranes to mi-
crotubules.
GMAP-210 Links the CGN to the Minus End
of Microtubules
We present here several lines of evidence showing that
GMAP-210 is a minus end microtubule-binding protein.
First, GMAP-210 binding to microtubules in vitro is
related to the number rather than the mass of micro-
tubule polymers. Second, the COOH-terminal domain
of GMAP-210, responsible for the microtubule-binding
property of the protein in vitro, localizes in vivo to the cen-
trosome, where the minus ends of microtubules accumu-
late. Moreover, it is able to disorganize the pericentriolar
material suggesting that it could displace other centroso-
mal proteins from the minus ends of microtubules. In the
presence of NZ, GMAP-210 does not remain associated
with the centrosome (Rios et al., 1994). Taxol treatment of
GMAP-210 overexpressing cells induced specific redistri-
bution of GMAP-210 enriched elements to the cell periph-
ery where they associated with one end of microtubule
bundles. Finally, in GMAP-210 overexpressing cells, a
dense network of short microtubules appears in the Golgi
area from which cytoplasmic microtubules seem to ema-
nate, consistent with the notion that binding or capping of
the minus ends of microtubules by proteins result in their
stabilization.
All data presented here support a model in which
GMAP-210 serves to maintain the structural integrity of
the Golgi apparatus by interacting with the minus end of
microtubules. The NH2-terminal domain binds to CGN
membranes whereas the COOH-terminal domain inter-
acts with the minus end of microtubules at the centrosome.
Remarkably, a low expression level of the COOH-termi-
nal domain leads to the centrosomal localization of GFP in
a manner identical to the centrosomal decoration obtained
with an antibody directed against g-tubulin (Moudjou et
al., 1996), or against a g-tubulin binding protein (Tassin et
al., 1998), i.e., the centriole pair and a domain surrounding
it. From the study of g-tubulin distribution in epithelial
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cells, Mogensen et al. (1997) have proposed that periph-
eral docking elements distinct from nucleating elements
could be closely associated with centrosomes. In their
model, microtubule minus ends would be capped and sta-
bilized before being released from nucleating elements,
which would remain in the juxtacentriolar vicinity to nu-
cleate new microtubules. Control mechanisms would en-
sure that a microtubule is anchored to the centrosome pe-
riphery or released. Several reports have indeed suggested
that centrosomally nucleated microtubules can escape to
other locations, particularly in neurons (Ahmad and Baas,
1995) but also in other cell types (Vorobjev and Chentsov,
1983; Belmont et al., 1990; Keating et al., 1997).
Based on this idea, one could propose that free microtu-
bule ends could be captured by GMAP-210 via its COOH-
terminal domain. This might also account for the existence
of a subpopulation of short, stable microtubules that colo-
calizes with the Golgi apparatus (Schulze and Kirschner,
1987). This subpopulation is rich in detyrosinated microtu-
bules (Skoufias et al., 1990) and we have shown that
GMAP-210 is specifically enriched in a microtubule frac-
tion with similar characteristics. In this view, CGN mem-
branes, rather than the centrosome itself, would be the
anchoring sites for microtubules participating in Golgi dy-
namics and stability.
A direct homologue of GMAP-210 has not been found
in the yeast genome database. This is consistent with the
fact that in lower eukaryotic cells no spatial segregation
between the ER and the Golgi apparatus exists. In such
cells, the Golgi complex is often found next to the ER sites
and pre-Golgi elements form the first cisternae of the
Golgi stack. However, in many eukaryotic cells the Golgi
apparatus is centered around the centrosome and actively
maintained there. Our data uncover a critical role for the
CGN in this process and identify GMAP-210 as an impor-
tant factor in mediating both the localization and the in-
tegrity of this Golgi compartment. During mitosis, the
microtubule dynamics changes and the centrosomal local-
ization of the Golgi apparatus is lost. One can speculate
that GMAP-210 could be a target for the mitotic regula-
tion of the CGN. Since GMAP-210 remains bound to
Golgi membranes during mitosis (unpublished results),
the obvious candidate for this mitotic regulation is the mi-
crotubule-binding domain. It is interesting to note in this
regard that the COOH-terminal domain has two putative
cyclin-dependent kinase phosphorylation sites. Experi-
ments are now in progress to test this hypothesis.
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